Filippo Acconcia

Filippo Acconcia

Sep 19, 2017

Group 6 Copy 13
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

Activating brown fat to improve diabetes and obesity

Diabetes in childhood is life changing, needing daily insulin injections to get strict blood sugar control...

Understanding immune system paralysis in times of bacterial stress

Sepsis is a life-threatening condition in which the body's immune response to infection injures its own tissues...

Campaign Ended